Skip to content

QuarterlyIQ Insights · BMY

Earnings

Next print, the company's guidance track record, and the earnings events we've seen in the last few years.

Next earnings

—
Earnings-day expected move
—

Average absolute move on past earnings days.

Realized vol (30d)
29.3%

Annualized — recent baseline volatility.

Guidance track record

Met or beat
—

Of the last 0 guided quarters.

Avg surprise
—

Actual vs. guided EPS, signed.

Post-call reaction
-0.9%

Excess return vs. sector ETF, day after print.

Guidance credibility score
—
Post-call reaction score
42

Earnings events

Earnings prints and pre-announcements detected in the SEC filing stream.

2 shown
  • 2026-04-30earnings inline
    BMY — earnings in line

    Results of Operations and Financial Condition. On April 30, 2026, Bristol-Myers Squibb Company (the “Company”) issued a press release (the “Earnings Press Release”) on its website at www.bms.com announcing its financial results for the first quarter of 2026. A copy of the Earnings Press Release is furnished pursuant to this

    neutral67
  • 2026-02-05earnings miss
    BMY — earnings miss

    Results of Operations and Financial Condition. On February 5, 2026, Bristol-Myers Squibb Company (the “Company”) issued a press release (the “Earnings Press Release”) on its website at www.bms.com announcing its financial results for the fourth quarter of 2025 and full year of 2025. A copy of the Earnings Press Release is furnished pursuant to this

    negative80
Coming next

EPS / revenue actuals and consensus per quarter (8-quarter history) need a mart view over AlphaVantage EARNINGS + EARNINGS_ESTIMATES — the backend ingest exists but isn't exposed to the frontend yet. Once that lands we can show beat/miss, surprise size, and forward consensus on this tab.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.